584 Participants Needed

Shoulder Arthroplasty for Shoulder Conditions

Recruiting at 14 trial locations
RB
JS
AC
AA
CL
Overseen ByCayla Lafollette, BS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Zimmer Biomet
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.

What data supports the effectiveness of the Zimmer Biomet Shoulder Arthroplasty Systems treatment?

Research shows that the Zimmer Biomet glenoid vault reconstruction system (VRS) used in reverse shoulder arthroplasty has acceptable short-term outcomes and complication rates. Additionally, the TESS stemless shoulder prosthesis, which is part of the Zimmer Biomet systems, has shown maintained fixation and stability after three years, indicating its effectiveness in shoulder arthroplasty.12345

Is shoulder arthroplasty generally safe for humans?

Research indicates that stemless shoulder arthroplasty systems, like the TESS and other similar implants, have evolved to reduce complications such as osteolysis (bone loss), stress shielding, and periprosthetic fractures (fractures around the implant). These systems are considered safe and effective, with improvements in fixation and stability over time.24567

What makes the Zimmer Biomet Shoulder Arthroplasty Systems treatment unique for shoulder conditions?

The Zimmer Biomet Shoulder Arthroplasty Systems offer a modular design that allows for precise anatomical reconstruction of the shoulder joint, which can be tailored to individual patient needs. This system includes options like the stem-free shoulder, which avoids complications associated with traditional stemmed implants, making it a novel choice compared to standard shoulder arthroplasty treatments.13589

Research Team

RB

Ryan Boylan

Principal Investigator

Zimmer Biomet

Eligibility Criteria

This trial is for adults over 20 with shoulder issues like arthritis, fractures, or deformities who need a shoulder replacement and have a working deltoid muscle. It's not for those with neuromuscular diseases affecting the limb, severe bone conditions, infections near the joint, pregnant or breastfeeding women, vulnerable populations, or anyone unable to follow the study protocol.

Inclusion Criteria

Patient must be able and willing to sign the IRB/EC approved informed consent
I am 20 years old or older.
Patient must be able and willing to complete the protocol required follow-up
See 4 more

Exclusion Criteria

I have a significant shoulder injury or muscle paralysis.
I have a bone condition like osteoporosis or a metabolic disorder affecting my bones.
I have an infection near my shoulder that could affect a surgery site.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Zimmer Biomet Shoulder Arthroplasty System in primary or revision shoulder arthroplasty

Surgery and immediate post-operative period

Follow-up

Participants are monitored for safety and effectiveness after treatment, including radiographic evaluations and clinical assessments

2 years
Regular follow-up visits for radiographic and clinical assessments

Long-term Follow-up

Participants are monitored for implant survivorship and adverse events over a long-term period

10 years

Treatment Details

Interventions

  • Zimmer Biomet Shoulder Arthroplasty Systems
  • Zimmer Biomet Shoulder Arthroplasty Systems Instrumentation
Trial OverviewThe trial tests Zimmer Biomet Shoulder Arthroplasty Systems in patients needing new shoulders (primary) or replacements (revision). It checks if these implants are safe and work well by looking at patient scores on standard health scales, X-rays of their shoulders before and after surgery, and tracking any complications.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Zimmer Biomet Total Shoulder Arthroplasty SystemExperimental Treatment2 Interventions
Patients who are having primary or revision total shoulder arthroplasty who will receive a Zimmer Biomet Total Shoulder Arthroplasty System.

Zimmer Biomet Shoulder Arthroplasty Systems is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Sidus Stem-Free Shoulder for:
  • Osteoarthritis
  • Posttraumatic arthrosis
  • Focal avascular necrosis of the humeral head
  • Previous surgeries of the shoulder that do not compromise the fixation
🇺🇸
Approved in United States as Comprehensive Total Shoulder System for:
  • Osteoarthritis
  • Fracture
  • Rotator cuff arthropathy
  • Other non-inflammatory shoulder issues
🇨🇦
Approved in Canada as Sidus Stem-Free Shoulder for:
  • Osteoarthritis
  • Posttraumatic arthrosis
  • Focal avascular necrosis of the humeral head
  • Previous surgeries of the shoulder that do not compromise the fixation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Zimmer Biomet

Lead Sponsor

Trials
383
Recruited
67,800+
Dr. Nitin Goyal profile image

Dr. Nitin Goyal

Zimmer Biomet

Chief Medical Officer since 2021

MD from Harvard Medical School

Ivan Tornos profile image

Ivan Tornos

Zimmer Biomet

Chief Executive Officer since 2023

MBA from the University of Miami School of Business, BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business

Findings from Research

The UNIVERS 3-D prosthesis significantly improved shoulder function in 74 patients with glenohumeral osteoarthritis, with Constant scores increasing from 34.1 to 68.4 points after an average follow-up of 31.9 months.
The procedure demonstrated a low complication rate of 12.2% and a minimal incidence of radiolucent lines around the prosthesis, indicating both safety and efficacy in reconstructing shoulder anatomy.
[Clinical outcomes of treatment of glenohumeral osteoarthritis with new generation shoulder prosthesis].Tang, KL., Li, QH., Habermeyer, P.[2016]
In a study of 12 shoulders (11 patients) undergoing reverse shoulder arthroplasty with the custom glenoid vault reconstruction system (VRS), significant improvements were observed in pain and shoulder function scores after an average follow-up of 30 months, indicating its efficacy for complex glenoid deformities.
All implants remained stable without any complications, suggesting that the VRS technique is a safe option for both primary and revision shoulder arthroplasties.
Short-term outcomes of reverse shoulder arthroplasty using a custom baseplate for severe glenoid deficiency.Bodendorfer, BM., Loughran, GJ., Looney, AM., et al.[2021]
The modern cup arthroplasty system offers significant advantages over traditional humeral shaft arthroplasty, including the ability to avoid mandatory humeral head resection and the option to convert to a standard prosthesis if needed.
In a clinical trial involving 14 patients, the cup system demonstrated a notable improvement in shoulder function, with the Constant-Score increasing from an average of 23 to 55 points over a mean follow-up period of 6.1 months.
[Total shoulder arthroplasty vs. hemiarthroplasty].Arman, F.[2016]

References

[Clinical outcomes of treatment of glenohumeral osteoarthritis with new generation shoulder prosthesis]. [2016]
Short-term outcomes of reverse shoulder arthroplasty using a custom baseplate for severe glenoid deficiency. [2021]
[Total shoulder arthroplasty vs. hemiarthroplasty]. [2016]
Results of a new stemless shoulder prosthesis: radiologic proof of maintained fixation and stability after a minimum of three years' follow-up. [2016]
Placement of the stemless humeral component in the Total Evolutive Shoulder System (TESS). [2010]
Stemless Total Shoulder: A Review of Biomechanical Fixation and Recent Results. [2023]
Primary shoulder arthroplasty using a custom-made hip-inspired implant for the treatment of advanced glenohumeral arthritis in the presence of severe glenoid bone loss. [2018]
[Shoulder Arthroplasty. Surgical management]. [2021]
Surgical Complications After Reverse Total Shoulder Arthroplasty and Total Shoulder Arthroplasty in the United States. [2021]